Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp KoreafiledCriticalGreen Cross Corp Japan
Priority to JP9750080ApriorityCriticalpatent/JPS5724311A/ja
Publication of JPS5724311ApublicationCriticalpatent/JPS5724311A/ja
Publication of JPS6337089B2publicationCriticalpatent/JPS6337089B2/ja
α, γ-Diaminobutyric acid in seeds of twelve species of Lathyrus and identification of a new natural amino-acid, L-homoarginine, in seeds of other species toxic to man and domestic animals
The effects of duodenal infusion of tri-and dithiomolybdate on plasma copper and on the diamine oxidase activity of caeruloplasmin (EC1. 16.3. 1) in sheep
Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon